The Catholic University of America

 

 

 

Alumnus Timothy Moynahan, 1964, to Steer Funding Towards Virology Research

   Print Friendly and PDF

 


Catholic University Law School alumnus Timothy C. Moynahan has been elected as the 2014 chairman of the Board of Directors of The Global Virus Network, a coalition of the world’s foremost medical virology research centers working to prevent illness and death from pandemic viruses. 
 
Among his immediate tasks is to develop partnerships with multinational corporations and private benefactors in order to sustain the substantial funding required to address the serious threat and exorbitant financial impact posed by potentially pandemic viral disease threatening public health. 
 
“Viruses continue to take tragic tolls on humanity in many ways, with millions of lives lost each year and staggering costs to the global economy,” said Moynahan.
 
According to the World Health Organization, seasonal flu in the United States alone results in 40,000 deaths and $87.1 billion in economic losses, both directly in terms of health care, and indirectly through work days lost and other factors.

“One of my most important mandates is to raise awareness of the staggering impact of viruses on lives, commerce and businesses,” he added.
 
Moynahan is the founder of The Moynahan Law Firm, one of Connecticut’s most respected law firms. In addition to his role as chairman of the Board of the Global Virus Network, Moynahan has been elected to the board of directors of numerous corporations and charitable organizations, including the Post University MBA Advisory Council, the Advisory Board of the Institute of Human Virology, the International Network for Cancer Treatment and Research and president of the Connecticut Chapter of the Ireland Chamber of Commerce in the United States.
 
The Global Virus Network is a non-profit organization comprised of leading medical virologists from more than 20 countries. Its mission is to combat current and emerging pandemic viral threats through international collaborative research, training the next generation of medical virologists, and advocacy.